Cancer-Associated Thrombosis: An Overview
This review examines the epidemiology and pathophysiology of cancer-associated thrombosis, risk factors, and new predictive biomarkers for venous thromboembolism (VTE).
This review examines the epidemiology and pathophysiology of cancer-associated thrombosis, risk factors, and new predictive biomarkers for venous thromboembolism (VTE).
[Translational Lung Cancer Research] There is medical and public interest in lung cancer screening but the high prevalence of screen-detected pulmonary nodules, over-diagnosis concerns, cumulative radiation danger, and insufficient data on cost-efficiency of lung cancer screening remain concerns.
SERMs and aromatase inhibitors have been proven to be excellent agents in the preventive setting for ER-positive breast cancer, but newer agents must be found specifically for ER-negative breast cancers, which mostly occur in premenopausal women.
[Breast Cancer (Auckl)] Breast positioning is the key factor affecting a mammogram. Done properly, correct positioning maximizes the amount of breast tissue being imaged, eliminates most of the artifacts, and increases sensitivity of the mammogram.
[Cancer Control] Age has in impact on the biology of cancer, treatment goals, and barriers to treatment. Older patients are also currently under-represented in clinical trials, but this need not be the case.
[Clin Med Insights Oncol] Hypersensitivity reactions are a classic and serious side effect of cetuximab.